Dannex Ayrton Starwin Ltd

The current share price of Dannex Ayrton Starwin Ltd (DASPHARMA) on the Ghana Stock Exchange (GSE) is GHS 0.41, as of Monday, June 15, 2026. The share price was unchanged from the prior session's close of GHS 0.41.

DASPHARMA has gained 0.0% over the past four weeks, ranking 16th among all stocks listed on the Ghana Stock Exchange for the period.

Dannex Ayrton Starwin Ltd ranks 27th on the Ghana Stock Exchange by trading volume over the past three months (Apr 27 – Jun 15, 2026). A total of 5.2 thousand DASPHARMA shares worth GHS 2.1 thousand changed hands across 40 sessions, with an average daily turnover of 129 shares (GHS 53). The busiest session saw 2.1 thousand shares trade on May 7th.

Dannex Ayrton Starwin Ltd (GSE: DASPHARMA) is a Consumer Goods company listed on the Ghana Stock Exchange since 2013, with a market capitalisation of GHS 115M.

Dannex Ayrton Starwin PLC (DASPHARMA) is one of Ghana's leading pharmaceutical manufacturers, formed through the merger of three established pharmaceutical companies: Dannex Limited, Ayrton Drug Manufacturing, and Starwin Products. The combined entity produces a wide range of generic prescription medicines, over-the-counter health products, vitamins, and nutritional supplements, supplying retail pharmacies, hospitals, clinics, and government health facilities across Ghana and West Africa. DASPHARMA operates a modern, WHO Good Manufacturing Practice (GMP)-certified pharmaceutical manufacturing facility, enabling it to meet both domestic demand and export requirements across the Economic Community of West African States (ECOWAS) region. The pharmaceutical sector in Ghana is supported by government policies encouraging local drug manufacturing to reduce dependence on imported medicines. DASPHARMA listed on the Ghana Stock Exchange in 2013 and represents a relatively rare listed healthcare manufacturing company in Ghana. Investors follow DASPHARMA for its role in Ghana's healthcare supply chain, potential to grow export revenues within West Africa, and the long-term tailwinds of rising pharmaceutical consumption as Ghana's population and healthcare coverage expand. Market cap: approximately GHS 115 million. Ticker: DASPHARMA.